<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01842178</url>
  </required_header>
  <id_info>
    <org_study_id>CIRH-OLE:2013</org_study_id>
    <nct_id>NCT01842178</nct_id>
  </id_info>
  <brief_title>Endometrial Scratching in In Vitro Fertilization Cycles With Oocyte Donation</brief_title>
  <official_title>Randomized Prospective Study of Endometrial Injury in In Vitro Fertilization Cycles With Oocyte Donation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro de Infertilidad y Reproducci贸n Humana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro de Infertilidad y Reproducci贸n Humana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to evaluate the potential benefit in pregnancy rates produced by an&#xD;
      endometrial scratching made in an IVF cycle prior to embryo transfer in patients with donated&#xD;
      oocytes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, comparative, prospective, double Blind study.&#xD;
&#xD;
      The First stage of this study consists of revising the patients medical records to identify&#xD;
      possible candidates. Patients indicated are randomized into two groups: experimental and&#xD;
      control. They are followed up to 12 week of pregnancy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Principal investigator retired from the project&#xD;
  </why_stopped>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>biochemical pregnancy</measure>
    <time_frame>14-16 days post-follicular punction</time_frame>
    <description>Determination of human chorionic gonadotropin blood levels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy</measure>
    <time_frame>6 pregnancy weeks</time_frame>
    <description>Ultrasound</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Evolutionary pregnancy</measure>
    <time_frame>12 weeks of pregnancy</time_frame>
    <description>telephone patient contact</description>
  </other_outcome>
  <other_outcome>
    <measure>abortion</measure>
    <time_frame>6-12 week of pregnancy</time_frame>
    <description>telephone contact of patients</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Subfertility</condition>
  <arm_group>
    <arm_group_label>scratching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will have an endometrial injury done on purpose, between 18-24 days prior to IVF cycle with a transfer catheter on the surgery outpatient department.&#xD;
Endometrial Injury&#xD;
Done between 18-24 days prior to embryo transfer cycle.&#xD;
Using transfer catheter.&#xD;
Introduction of the same to the uterine fundus.&#xD;
Systematic scrapping of the four uterine walls, lengthwise.&#xD;
Performed by a skilled doctor.&#xD;
Subsequent ultrasound control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scratching simulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will come to control visit between day 18-24. A scratching simulation will be done.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>scratching</intervention_name>
    <description>Endometrial Injury&#xD;
Done between 18-24 days prior to embryo transfer cycle.&#xD;
Using transfer catheter.&#xD;
Introduction of the same to the uterine fundus.&#xD;
Systematic scrapping of the four uterine walls, lengthwise.&#xD;
Performed by a skilled doctor.&#xD;
Subsequent ultrasound control.</description>
    <arm_group_label>scratching</arm_group_label>
    <arm_group_label>scratching simulation</arm_group_label>
    <other_name>endometrial enjury</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Do IVF cycle with donor eggs&#xD;
&#xD;
          -  Will adjust to protocol for the study.&#xD;
&#xD;
          -  Have signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinically significant systemic disease, hypothalamic or pituitary tumors&#xD;
&#xD;
          -  ovarian, uterine or breast cancer&#xD;
&#xD;
          -  hormonal abnormalities and / or medical , biochemistry, hematology pathology, which&#xD;
             might interfere with gonadotropin treatment.&#xD;
&#xD;
          -  known positivity for human immunodeficiency virus (HIV), hepatitis C or B virus (HCV /&#xD;
             HBV) of the candidate or her partner.&#xD;
&#xD;
          -  Uterine Factor(submucosal fibroids, intramural fibroids&gt; 4 cm)&#xD;
&#xD;
          -  Hydrosalpinx&#xD;
&#xD;
          -  Patients receiving immune treatment&#xD;
&#xD;
          -  Positive Diagnosis Thrombophilia&#xD;
&#xD;
          -  preimplantation genetic diagnosis needed&#xD;
&#xD;
          -  In case of using marital sperm are excluded the following patients:Altered male&#xD;
             karyotype, Altered Meiosis in testicular biopsy, Altered FISH, sperm Fragmentation&gt;&#xD;
             45%&#xD;
&#xD;
          -  Pregnancy contraindication&#xD;
&#xD;
          -  Known allergy to preparations containing estrogens or any of its excipients.&#xD;
&#xD;
          -  Simultaneous participation in another clinical trial with medication.&#xD;
&#xD;
          -  Do not want or can not adjust to study protocol.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>miguel angel checa, MD</last_name>
    <role>Study Director</role>
    <affiliation>Centro de Infertilidad y Reproducci贸n Humana</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro de Infertilidad y Reproducci贸n Humana</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>April 25, 2013</study_first_submitted>
  <study_first_submitted_qc>April 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2013</study_first_posted>
  <last_update_submitted>May 9, 2017</last_update_submitted>
  <last_update_submitted_qc>May 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

